Verve Therapeutics, Inc. short interest in 2023
In 2023, Verve Therapeutics, Inc.'s disclosed short interest ran from 20.77% of shares outstanding on 13 Jan 2023 to 18.40% on 29 Dec 2023, a change of -2.37 percentage points. The year's high was 22.56% on 30 Nov 2023 and its low 17.28% on 31 Jul 2023, averaging 19.95% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.30 days on 31 Jan 2023. Full history: Verve Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 20.77% (13 Jan 2023)
- End of year
- 18.40% (29 Dec 2023)
- Change
- -2.37 pp
- High
- 22.56% (30 Nov 2023)
- Low
- 17.28% (31 Jul 2023)
- Average
- 19.95%
- Highest days to cover
- 25.30 (31 Jan 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 20.77% | 19.46 | |
| 31 Jan 2023 | 20.81% | 25.30 | |
| 15 Feb 2023 | 22.03% | 23.01 | |
| 28 Feb 2023 | 22.16% | 19.62 | |
| 15 Mar 2023 | 22.15% | 14.39 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 21.83% | 16.97 | |
| 14 Apr 2023 | 21.72% | 13.44 | |
| 28 Apr 2023 | 21.22% | 23.27 | |
| 15 May 2023 | 20.38% | 21.33 | 10-Q filed, results (8-K) |
| 31 May 2023 | 20.00% | 21.50 | |
| 15 Jun 2023 | 18.67% | 17.89 | |
| 30 Jun 2023 | 19.16% | 14.39 | |
| 14 Jul 2023 | 19.24% | 21.41 | |
| 31 Jul 2023 | 17.28% | 22.50 | |
| 15 Aug 2023 | 17.53% | 17.35 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 18.71% | 19.22 | |
| 15 Sep 2023 | 18.74% | 16.67 | |
| 29 Sep 2023 | 19.12% | 14.99 | |
| 13 Oct 2023 | 17.91% | 15.50 | |
| 31 Oct 2023 | 19.90% | 9.32 | |
| 15 Nov 2023 | 20.94% | 3.89 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 22.56% | 8.32 | |
| 15 Dec 2023 | 17.63% | 7.43 | |
| 29 Dec 2023 | 18.40% | 10.99 |
See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.